GNRSU stock The Greenrose Holding Co. (PNK) at $0.000001 on 09 Apr 2026: outlook

GNRSU stock opened the U.S. market at $0.000001 on 09 Apr 2026 after a collapse from the prior close of $0.15. Trading volume was light at 145 shares and market capitalization shows roughly $13.00. This intraday drop framed The Greenrose Holding Company Inc. (GNRSU) as a top loser on the PNK exchange during market hours, raising questions on liquidity, valuation, and near-term risk for investors.

Market move and intraday data for GNRSU stock

GNRSU stock fell from a previous close of $0.15 to $0.000001, a change of about -99.99933% on low volume of 145 shares. The day high and day low were both $0.000001, indicating a thinly traded print on the PNK exchange in the United States. This price action marks GNRSU among top losers in the small-cap healthcare group today, driven by a dramatic mechanical drop rather than steady selling.

Fundamentals and valuation context for The Greenrose Holding Company Inc.

The Greenrose Holding Company Inc. operates in Healthcare, specifically Drug Manufacturers – Specialty & Generic, and reports EPS of 3.097 and book value per share of 4.30. Trailing metrics show a price average 50-day of $0.15 and market cap reported near $13.00. Many standard ratios are distorted by the microprice, producing a P/E shown as a near-zero figure in the feed. Investors should treat headline ratios cautiously given the extreme share price move.

Liquidity, shares outstanding and trading risks for GNRSU stock

GNRSU trades on the PNK with 12,853,627 shares outstanding and only 145 shares traded today, highlighting extreme liquidity risk. Low volume and a near-zero quote can trigger wide spreads, stale prints, and execution risk for larger orders. Short-term traders face elevated volatility and possible quote suspensions on retail platforms when a stock prints at micro prices.

Meyka Grade and valuation: GNRSU stock technical and fundamental score

Meyka AI rates GNRSU with a score out of 100: 63.264362897282055 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The grade reflects mixed fundamentals and heavy valuation noise, and is not guaranteed; this is informational and not financial advice.

Sector comparison and catalysts influencing GNRSU stock

The Healthcare cannabis segment showed mixed sentiment today, with larger peers reporting steadier volumes. GNRSU’s decline is idiosyncratic and not tied to a clear sector-wide selloff. Key catalysts to watch include any company filings, liquidity restorations, or corporate updates from The Greenrose Holding Company Inc., and broader regulatory news that affects cannabis operators in the United States.

Trading strategy and risk management for top losers like GNRSU stock

Given GNRSU stock’s microprice, traders should limit position size and set strict entry and exit rules. Use limit orders and avoid market orders that could suffer wide fills. Consider the high cash conversion cycle and negative working capital per the company’s metrics before sizing trades. For long-term investors, focus on balance sheet recovery and clear operational updates before adding exposure.

Final Thoughts

Key takeaways: GNRSU stock printed at $0.000001 on 09 Apr 2026 after a nearly -99.99933% swing from the prior close of $0.15, driven by extreme illiquidity on the PNK exchange in the United States. Meyka AI’s data shows EPS of 3.097, 12,853,627 shares outstanding, and a market cap near $13.00, but the quote distortion makes standard multiples unreliable. Meyka AI’s forecast model projects $0.00, implying essentially -100.00% downside versus the current microprice; forecasts are model-based projections and not guarantees. Our grade is B (63.26) with a HOLD suggestion based on mixed metrics, sector context, and liquidity concerns. Short-term traders should favor strict risk controls. Longer-term investors should await clear corporate disclosures or liquidity improvement before reconsidering GNRSU stock exposure. For live quotes and company filings see Greenrose website and the company profile at Financial Modeling Prep. Meyka AI provided this analysis as an AI-powered market analysis platform and it does not constitute investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.